Laurel Wealth Advisors (California)’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,224
Closed -$227K 648
2022
Q3
$227K Buy
+4,224
New +$217K 0.02% 570
2022
Q2
Sell
-3,464
Closed -$229K 691
2022
Q1
$229K Hold
3,464
0.02% 677
2021
Q4
$346K Buy
+3,464
New +$358K 0.03% 571

Other funds holding GH

Laurel Wealth Advisors (California)'s GH Position: Q4 2022 in Review

Laurel Wealth Advisors (California) sold out of Guardant Health (GH) in Q4 2022, closing a stake of 4,224 shares — an estimated $227K sold.

Laurel Wealth Advisors (California) first reported a position in GH in Q4 2021 and held it in 3 quarters. The position peaked at $346K in Q4 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Laurel Wealth Advisors (California) reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (California) sold 4,224 Guardant Health shares in Q4 2022, an estimated $227K.
  • Laurel Wealth Advisors (California) first reported a position in Guardant Health in Q4 2021 and held it in 3 quarters.
  • Laurel Wealth Advisors (California)'s Guardant Health position peaked at $346K in Q4 2021.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.